Stock Events

Stock Events

PRF Technologies 

$0.9717
37
-$0.01-0.54% Monday 20:00
-$0.02-2.23%Monday 23:57After hours

Statistics

Day High
1.02
Day Low
0.96
52W High
7.95
52W Low
0.852
Volume
41,318
Avg. Volume
320,388
Mkt Cap
3.4M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

26MarExpected
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q3 2025
Q4 2025
-26.4
-18.4
-10.4
-2.4
Expected EPS
N/A
Actual EPS
N/A

Financials

-29,541.18%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
17,000Revenue
-5.02MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PRFX. It's not an investment recommendation.
NVIDIA
10
NVDA
Microsoft
8
MSFT
Amazon
8
AMZN
Tesla
8
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pacira BioSciences
PCRX
Mkt Cap1B
Pacira Biosciences specializes in non-opioid pain management, directly competing with PainReform's post-operative pain solutions.
Heron Therapeutics
HRTX
Mkt Cap55.85M
Heron Therapeutics focuses on improving the patient experience by developing best-in-class treatments for acute and chronic pain, similar to PainReform's objectives.
Trevena
TRVN
Mkt Cap9,501
Trevena, Inc. develops novel medicines for patients affected by pain, offering alternatives that could compete with PainReform's products.
Evolus
EOLS
Mkt Cap526.42M
Evolus operates in the medical aesthetics market but its focus on non-surgical treatments could indirectly compete with PainReform's pain management solutions.
CorMedix
CRMD
Mkt Cap611.86M
CorMedix Inc. focuses on preventing and treating infections and inflammatory diseases, which could overlap with PainReform's target market in post-operative care.
Nektar Therapeutics
NKTR
Mkt Cap1.95B
Nektar Therapeutics works on drug development that includes pain management solutions, potentially competing with PainReform's portfolio.
Collegium Pharmaceutical
COLL
Mkt Cap733.48M
Collegium Pharmaceutical is dedicated to developing and commercializing new medications for pain management, directly competing with PainReform.

About

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.
Show more...
CEO
Efraim Cohen-Arazi
Employees
6
Country
Israel
ISIN
IL0011651580

Listings

BOATS
BOATS
PRFX.BOATS
XNAS
US
PRFX

0 Comments

Share your thoughts

FAQ

What is PRF Technologies stock price today?▼
The current price of PRFX is $0.97 USD — it has decreased by -0.54% in the past 24 hours. Watch PRF Technologies stock price performance more closely on the chart.
What is PRF Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange PRF Technologies stocks are traded under the ticker PRFX.
Is PRF Technologies stock price growing?▼
PRFX stock has risen by +4.37% compared to the previous week, the month change is a +1.11% rise, over the last year PRF Technologies has showed a -86.31% decrease.
What is PRF Technologies market cap?▼
Today PRF Technologies has the market capitalization of 3.4M
What is PRF Technologies revenue for the last year?▼
PRF Technologies revenue for the last year amounts to 17,000 USD.
What is PRF Technologies net income for the last year?▼
PRFX net income for the last year is -5.02M USD.
How many employees does PRF Technologies have?▼
As of September 29, 2026, the company has 6 employees.
In which sector is PRF Technologies located?▼
PRF Technologies operates in the Health & Wellness sector.
When did PRF Technologies complete a stock split?▼
The last stock split for PRF Technologies was on February 06, 2026 with a ratio of 1:5.
Where is PRF Technologies headquartered?▼
PRF Technologies is headquartered in Tel Aviv, Israel.